News &amp; Updates

VTE prophylaxis safe to administer in high-risk paediatric trauma patients

Use of chemical venous thromboembolism (VTE) in paediatric trauma patients who meet the high-risk criteria is safe and does not appear to carry any risk of bleeding complications, according to a study.

VTE prophylaxis safe to administer in high-risk paediatric trauma patients

Immediate brace weaning maintains similar outcomes to gradual weaning in adolescent idiopathic scoliosis

24 Oct 2024 by

A randomized clinical trial (RCT) conducted by researchers from the University of Hong Kong (HKU) demonstrated a very similar maintenance of outcomes and health-related quality of life (HRQoL) with immediate or gradual brace weaning in adolescent idiopathic scoliosis (AIS).

Immediate brace weaning maintains similar outcomes to gradual weaning in adolescent idiopathic scoliosis

Hidradenitis suppurativa raises maternal, offspring risks

23 Oct 2024

Hidradenitis suppurativa (HS) poses increased risk of adverse maternal and offspring outcomes not only during the peripartum period but also in the long term, according to a study.

Hidradenitis suppurativa raises maternal, offspring risks

23 Oct 2024

Insufficient physical activity, smoking common in childhood cancer survivors

The possibility of risky behaviours does not significantly differ between adult survivors of childhood cancer and the general population, reports a study. However, the rates of physical activity may be lower and smoking higher among survivors.

Insufficient physical activity, smoking common in childhood cancer survivors

Too much or too little folate during pregnancy may raise heart risk in offspring

In early to mid-pregnancy, low or excessively high maternal serum folate levels carry a heightened risk of congenital heart disease (CHD) in the offspring, as shown in a study.

Too much or too little folate during pregnancy may raise heart risk in offspring

Original New Drug Application Approvals by US FDA (1-15 October 2024)

New drug applications approved by US FDA as of 1-15 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 October 2024)

Histologic EoE control tied to lower chance of stricture development in children

Children with eosinophilic esophagitis (EoE) with a period of histologic disease control and diagnosed at younger ages appear to have reduced odds of developing esophageal strictures, according to a cohort study with >10 years of follow-up.

Histologic EoE control tied to lower chance of stricture development in children

Original New Drug Application Approvals by US FDA (16-30 September 2024)

New drug applications approved by US FDA as of 16-30 September 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2024)